Terms ending in 2043
Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,655,160 | Kras G12D Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 12,686,692 | Kras G12D Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 12,698,271 | Crystalline Form of a SHP2 Inhibitor In force · High confidence | Array BioPharma Inc. | In force | High confidence | |
| US 12,447,153 | HER2 Mutation Inhibitors In force · High confidence | Array BioPharma Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.